Smart sensor aims to decode menopause symptoms
NCT ID NCT07022925
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This observational study tests whether a wearable sensor can accurately track perimenopausal symptoms like hot flashes, anxiety, and sleep quality. About 110 women aged 35-55 will wear the device and report their symptoms daily via an app. The goal is to see if the device's algorithm matches what women report, potentially offering a new way to monitor menopause without guesswork.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a non-invasive wearable device that helps women and doctors better track and manage perimenopausal symptoms in real time.
- What could go wrong
- This is an early observational study with only 110 participants, so results may not apply to all women. The device's accuracy depends on self-reported data, which can be subjective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 110 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Oct 2025
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
N/A - virtual study. Participants are recruited online.
- Ages
-
35 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Females between 35-55 years of age, inclusive 2. Self-reported perimenopausal women experiencing hot flushes or night sweats 3. Individuals of child-bearing potential must confirm they are not pregnant, do not plan to become pregnant, and agree to use a medically approved method of birth control for the duration of the study. Acceptable methods of birth control include: * Double-barrier method * Intrauterine devices * Non-heterosexual lifestyle or agrees to use contraception if planning on changing to heterosexual partner(s) * Vasectomy of partner at least 6 months prior to screening * Abstinence 4. Agrees to maintain current lifestyle as much as possible throughout the study, including diet, exercise, supplements/medications, and sleep 5. Provided voluntary and informed consent to participate in the study 6. Generally healthy as determined by medical history with no unstable diagnosed medical conditions Exclusion Criteria: 1. Allergy or sensitivity to adhesive used for wearing the investigational device 2. Self-reported use of a pacemaker 3. Self-reported unstable diagnosed anxiety disorder 4. Self-reported sleep disorder requiring medical treatment 5. Self-reported skin conditions or sensitive skin around the area of application 6. Self-reported surgery in the past three months or individuals who have planned surgery during the course of the study 7. Alcohol intake average of ˃1 standard drink per day 8. Alcohol or drug abuse within the last 12 months that has required treatment 9. Current use of prescribed and/or over-the-counter (OTC) medications/supplements that may impact data recorded by the investigational device (see Section 7.3) 10. Participation in other clinical research studies 30 days prior to screening 11. Individuals who are unable to give informed consent 12. Any other condition or lifestyle factor, that may adversely affect the participant's ability to complete the study or its measures or pose significant risk to the participant
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Menopausal and postmenopausal disorders are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
KGK Science Inc.
RECRUITINGLondon, Ontario, N6B3L1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Muscle-Saving app: a new weapon in the GLP-1 weight loss battle?
- Gut bacteria may soothe menopause symptoms — a trial puts it to the test
- Hormone therapy may shield menopausal hearts and brains — a trial puts it to the test
- A fiber supplement may help perimenopausal women — a trial puts it to the test
- Ear acupressure may offer Drug-Free sleep relief for menopausal women
- Menopause heart risk targeted by tailored exercise and diet programs